Sanggenol F exhibits significant anti-inflammatory and antioxidant activities, making it a promising candidate for therapeutic applications in chronic inflammatory diseases. It has been studied for its ability to inhibit pro-inflammatory cytokines and suppress oxidative stress markers in cellular models. Additionally, Sanggenol F shows potential in cancer research due to its cytotoxic effects on certain tumor cell lines, particularly in liver and colon cancer cells, where it induces apoptosis and cell cycle arrest. Its neuroprotective properties are also under investigation, with evidence suggesting it may help protect neuronal cells from oxidative damage, indicating possible use in neurodegenerative conditions like Alzheimer’s disease. Furthermore, Sanggenol F contributes to metabolic health by modulating pathways involved in glucose and lipid metabolism, highlighting its relevance in managing metabolic disorders such as diabetes and fatty liver disease.